Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Xenoport Inc (NASDAQ:XNPT)

4.40
Delayed Data
As of Apr 29
 -0.25 / -5.38%
Today’s Change
3.35
Today|||52-Week Range
7.86
-19.85%
Year-to-Date
No recent news for Xenoport Inc.

Today’s Trading

Previous close4.65
Today’s open4.65
Day’s range4.38 - 4.68
Volume344,555
Average volume (3 months)710,895
Market cap$279.5M
Dividend yield--
Data as of 4:00pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)-60.49%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)-12.18%
P/E ratioNM
Price/Sales8.43
Price/Book13.74

Competitors

 Today’s
change
Today’s
% change
INFIInfinity Pharmaceuti...-0.17-2.85%
AGTCApplied Genetic Tech...-0.48-2.96%
IMDZImmune Design Corp-1.18-7.96%
VSARVersartis Inc-0.67-6.89%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 6, 2016
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$41.2M
Annual profit (last year)-$82.3M
Net profit margin-199.98%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Vincent J. Angotti
Chief Financial Officer &
Senior VP-Finance
William G. Harris
Corporate headquarters
Santa Clara, California

Forecasts

Partner Offers

Search for Jobs